StonvexLoading…
StonvexStonvexStonvexCore line items from QSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $258.00K | $2.44M | $1.99M | $1.43M |
Operating Income | $-24.05M | $-116.10M | $-95.00M | $-55.23M |
Net Income | $-21.67M | $-101.34M | $-83.73M | $-28.84M |
EPS (Diluted) | $-0.10 | $-0.51 | $-0.44 | $-0.26 |
Total Assets | $213.35M | $245.61M | $260.13M | $254.41M |
Total Liabilities | $12.60M | $25.38M | $24.97M | $33.42M |
Cash & Equivalents | $36.20M | $21.64M | $30.91M | $22.19M |
Free Cash Flow OCF − CapEx | $-25.92M | $-97.23M | $-80.90M | $-47.98M |
Shares Outstanding | 216.47M | 197.76M | 191.75M | 182.97M |